Back to Search Start Over

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate.

Authors :
Uraki R
Ito M
Kiso M
Yamayoshi S
Iwatsuki-Horimoto K
Sakai-Tagawa Y
Imai M
Koga M
Yamamoto S
Adachi E
Saito M
Tsutsumi T
Otani A
Kashima Y
Kikuchi T
Theiler J
Yotsuyanagi H
Suzuki Y
Korber B
Kawaoka Y
Source :
The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2023 May; Vol. 34, pp. 100777. Date of Electronic Publication: 2023 May 11.
Publication Year :
2023

Abstract

Competing Interests: Y.Kawaoka has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. T.K. is employed by Nihon Sumo Kyokai. The remaining authors declare that they have no competing interests.

Details

Language :
English
ISSN :
2666-6065
Volume :
34
Database :
MEDLINE
Journal :
The Lancet regional health. Western Pacific
Publication Type :
Academic Journal
Accession number :
37193320
Full Text :
https://doi.org/10.1016/j.lanwpc.2023.100777